CDER's Latest "From our perspective" by Richard Pazdur, M.D.

Expedited oncology drug approvals

In this article, Dr. Richard Pazdur highlights some of the 2015 approvals from the Office of Hematology and Oncology Products and discusses a few of the expedited review programs used by the office.

More from Richard Pazdur, M.D.

From our perspective: The Collection